Nanocarrier drug delivery system: promising platform for targeted depression therapy

X Feng, P Jia, D Zhang - Frontiers in Pharmacology, 2024 - frontiersin.org
Depression is a chronic mental disorder characterized by persistent low mood and loss of
interest. Treatments for depression are varied but may not be sufficient cure. Drug-based …

Special Section on Nanotechnology-Based Delivery Strategies for Protein and Peptide Therapeutics

A Mittal, D Chitkara - The Journal of Pharmacology and …, 2024 - jpet.aspetjournals.org
Protein and peptide therapeutics score better than small-molecule therapeutics owing to
their higher potency, greater specificity, and fewer immunological responses. Furthermore …

Nanopharmacology as a new approach to treat neuroinflammatory disorders

SG Menéndez, W Manucha - Translational Neuroscience, 2023 - degruyter.com
Neuroinflammation, a complex process involving the activation of microglia, astrocytes, and
other immune cells in the brain, plays a role in neurodegeneration and psychiatric disorders …

Peptide-Based Therapeutics in Fungal Infections: Challenges and Innovations

R Vishwas - Current Pharmaceutical Research, 2025 - cpr.org.in
In light of the growing resistance to antifungal medications, peptide-based therapies have
become a viable substitute for treating fungal infections. These peptides, derived from …

Nanopharmacology as a new approach to treat neuroinflammatory disorders

SMM García Menéndez, WAF Manucha - 2023 - ri.conicet.gov.ar
Neuroinflammation is a complex process that involves the activation of microglia, astrocytes,
and other immune cells in the brain. This response is normal to injury or infection but can …